Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen NeuMoDx Human Adenovirus Assay Receives CE Mark

NEW YORK – Qiagen said on Thursday that its NeuMoDx HAdV Quant Assay for the identification and quantification of human adenovirus DNA has received CE-IVD certification.

Qiagen developed the assay in partnership with Sentinel Diagnostics, and the test adds to the current NeuMoDx transplant assay menu that already includes CE-marked tests for cytomegalovirus, Epstein-Barr virus, and BK virus viral load monitoring for the management of immunocompromised patients, such as those who have undergone organ transplantation.

All of these assays use Qiagen's automated, three-step NeuMoDx workflow that extracts DNA from blood or urine to isolate target nucleic acids followed by real-time PCR to target conserved sequences in the genomes of target viruses.

The new assay is also the 15th overall available on the NeuMoDx 96 and 288 Molecular Systems, which enables true random access of Qiagen-developed tests as well as laboratory-developed tests.

Qiagen acquired the remaining stake in NeuMoDx in September 2020 after having acquired a minority stake in the Ann Arbor, Michigan-based diagnostic developer in 2018 as part of a test menu development deal.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.